Tailoring of Vaccine-Focused Messages: Disease Salience

NACompletedINTERVENTIONAL
Enrollment

1,320

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 1, 2017

Study Completion Date

May 1, 2017

Conditions
Human Papillomavirus
Interventions
BEHAVIORAL

Baseline Survey

The baseline survey is a combination of the Vaccine Confidence Scale, and a short form of the Parents' Attitudes about Childhood Vaccines (PACV) Scale. Participants will be asked an additional 10 questions developed as a part of a behavioral phenotyping questionnaire to assess behavioral biases at baseline within the study population. Demographic information and intent to vaccinate will also be collected.

BEHAVIORAL

Current CDC Message

Participants randomized to the current CDC message arm will read a message taken almost directly from the CDC Vaccine Information Sheet (VIS) on HPV. This message was minimally altered for length and clarity.

BEHAVIORAL

Cervical Cancer Message

Participants randomized to the cervical cancer messaging arm will receive a message developed by the study team to appeal tenants of the Health Belief Model (self-efficacy, perceived benefit) and on the purity tenant of the moral foundations theory.

BEHAVIORAL

Control Message

Participants randomized to the non-vaccine related control arm will read a bird-feeding passage.

BEHAVIORAL

Post-Intervention Survey

The immediate post-intervention survey will include questions from the Vaccine Confidence Scale and the PACV short scale. Intent to vaccinate will be assessed.

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT03002324 - Tailoring of Vaccine-Focused Messages: Disease Salience | Biotech Hunter | Biotech Hunter